JP2018518460A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018518460A5 JP2018518460A5 JP2017556593A JP2017556593A JP2018518460A5 JP 2018518460 A5 JP2018518460 A5 JP 2018518460A5 JP 2017556593 A JP2017556593 A JP 2017556593A JP 2017556593 A JP2017556593 A JP 2017556593A JP 2018518460 A5 JP2018518460 A5 JP 2018518460A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- mammal
- body weight
- weight
- composition comprises
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 10
- 241000124008 Mammalia Species 0.000 claims 5
- 230000037396 body weight Effects 0.000 claims 4
- 206010064930 Age-related macular degeneration Diseases 0.000 claims 2
- 208000002780 Macular Degeneration Diseases 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 235000006010 Bixa orellana Nutrition 0.000 claims 1
- 240000000318 Bixa orellana Species 0.000 claims 1
- 210000004369 Blood Anatomy 0.000 claims 1
- ZVKOASAVGLETCT-UOGKPENDSA-N Norbixin Chemical compound OC(=O)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O ZVKOASAVGLETCT-UOGKPENDSA-N 0.000 claims 1
- ZVKOASAVGLETCT-PYDCZAKGSA-N Norbixin Natural products O=C(O)/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C(=O)O)\C)/C)\C)/C ZVKOASAVGLETCT-PYDCZAKGSA-N 0.000 claims 1
- 210000001525 Retina Anatomy 0.000 claims 1
- 208000007014 Retinitis Pigmentosa Diseases 0.000 claims 1
- 206010062766 Stargardt's disease Diseases 0.000 claims 1
- 229930003268 Vitamin C Natural products 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- 229940046009 Vitamin E Drugs 0.000 claims 1
- 239000001670 anatto Substances 0.000 claims 1
- 235000012665 annatto Nutrition 0.000 claims 1
- 235000012978 bixa orellana Nutrition 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 230000037406 food intake Effects 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 239000002417 nutraceutical Substances 0.000 claims 1
- 230000003711 photoprotective Effects 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 239000000790 retinal pigment Substances 0.000 claims 1
- 238000001228 spectrum Methods 0.000 claims 1
- 235000019154 vitamin C Nutrition 0.000 claims 1
- 239000011718 vitamin C Substances 0.000 claims 1
- 150000003700 vitamin C derivatives Chemical class 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
- 150000003712 vitamin E derivatives Chemical class 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 235000016804 zinc Nutrition 0.000 claims 1
Claims (11)
- Bixa Orellana種子からの抽出物の精製で得られるノルビキシンを含む組成物を哺乳動物に、1日あたり、0.48mg/kg(体重)〜48mg/kg(体重)の量で投与することを含む、哺乳動物において網膜色素上皮(RPE)の細胞を光保護する方法。
- 前記組成物は95重量%を超えるノルビキシンを含む、請求項1に記載の方法。
- 前記組成物は、亜鉛、ビタミンC及びビタミンEから選択される少なくとも1種の要素を含む、請求項1に記載の方法。
- 前記組成物は栄養補助食品又は薬物の形態である、請求項1に記載の方法。
- 前記組成物は、経口摂取、眼内注射、全身注射又は血中への注入が許容可能な担体を含む、請求項1に記載の方法。
- 前記組成物は、可視光スペクトルの青色バンドに対応し、435nm〜490nmの波長を有する青色放射線への曝露により引き起こされる網膜への損傷を防止するために投与される、請求項1に記載の方法。
- 前記組成物は、哺乳動物において加齢黄斑変性(ARMD)を治療するために投与される、請求項1に記載の方法。
- 前記組成物は、哺乳動物においてシュタルガルト病及び網膜色素変性症の少なくとも一方を治療するために投与される、請求項1に記載の方法。
- 前記哺乳動物への前記組成物の投与量は、1日あたり、0.6mg/kg(体重)〜20mg/kg(体重)である、請求項1に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1553957 | 2015-04-30 | ||
FR1553957A FR3035589B1 (fr) | 2015-04-30 | 2015-04-30 | Composition pour la protection des cellules de l'epithelium pigmentaire retinien |
PCT/FR2016/051001 WO2016174360A1 (fr) | 2015-04-30 | 2016-04-28 | Composition contenant de la norbixine pour la protection des cellules de l'epithelium pigmentaire retinien |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018518460A JP2018518460A (ja) | 2018-07-12 |
JP2018518460A5 true JP2018518460A5 (ja) | 2019-04-25 |
JP6660401B2 JP6660401B2 (ja) | 2020-03-11 |
Family
ID=53758384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017556593A Active JP6660401B2 (ja) | 2015-04-30 | 2016-04-28 | 網膜色素上皮の細胞を保護するためのノルビキシン含有組成物 |
Country Status (15)
Country | Link |
---|---|
US (1) | US10314804B2 (ja) |
EP (1) | EP3288551B1 (ja) |
JP (1) | JP6660401B2 (ja) |
KR (1) | KR102575312B1 (ja) |
CN (1) | CN107708685B (ja) |
AU (1) | AU2016256637A1 (ja) |
BR (1) | BR112017023264A2 (ja) |
CA (1) | CA2984405C (ja) |
ES (1) | ES2752061T3 (ja) |
FR (1) | FR3035589B1 (ja) |
IL (1) | IL255276A0 (ja) |
MX (1) | MX2017013918A (ja) |
PL (1) | PL3288551T3 (ja) |
RU (1) | RU2715889C2 (ja) |
WO (1) | WO2016174360A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3078252B1 (fr) * | 2018-02-28 | 2020-08-14 | Biophytis | Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation |
KR20200134935A (ko) | 2019-05-24 | 2020-12-02 | (주)비지엔케어 | 커큐민을 유효성분으로 포함하는 인간 망막색소상피세포 증식 개선용 약학 조성물 |
FR3105790B1 (fr) | 2019-12-26 | 2022-01-14 | Biophytis | Composés chimiques ciblant l’œil et leur utilisation dans le traitement de maladies oculaires |
KR20210008884A (ko) | 2021-01-08 | 2021-01-25 | (주)비지엔케어 | 커큐민을 유효성분으로 포함하는 인간 망막색소상피세포 증식 개선용 조성물 및 기능성 식품 조성물 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1154172A (fr) | 1955-07-05 | 1958-04-03 | Rollei Werke Franke Heidecke | étui de protection pour appareils photographiques |
AU2001256855A1 (en) * | 2000-05-08 | 2001-11-20 | N.V. Nutricia | Preparation for the prevention and treatment of ocular disorders |
US20070059381A1 (en) * | 2003-06-20 | 2007-03-15 | Barker Ronnie C | Treatment of amd with combination of ingredients |
WO2005110375A1 (en) * | 2004-05-08 | 2005-11-24 | Paul Edward L Jr | Nutritional supplement for treatment of ocular diseases |
WO2006055526A2 (en) * | 2004-11-16 | 2006-05-26 | Nu-Tein Co., Inc. | Compositions useful to treat ocular neovascular diseases and macular degeneration |
JP2008179632A (ja) * | 2006-12-29 | 2008-08-07 | Fuji Chem Ind Co Ltd | 抗酸化剤 |
JP5550854B2 (ja) * | 2009-06-10 | 2014-07-16 | 理研ビタミン株式会社 | 一重項酸素消去剤 |
FR2947173B1 (fr) * | 2009-06-25 | 2012-01-27 | Inst Biophytis | Composition alimentaire destinee a la protection solaire |
JP2012097003A (ja) * | 2010-10-29 | 2012-05-24 | Gifu City | ビキシン誘導体及び細胞保護剤 |
FR2975008B1 (fr) * | 2011-05-13 | 2014-03-07 | Inst Biophytis | Utilisation de composes et composition pour le traitement de la degenerescence maculaire liee a l'age (dmla) |
-
2015
- 2015-04-30 FR FR1553957A patent/FR3035589B1/fr active Active
-
2016
- 2016-04-28 MX MX2017013918A patent/MX2017013918A/es active IP Right Grant
- 2016-04-28 US US15/570,720 patent/US10314804B2/en active Active
- 2016-04-28 CA CA2984405A patent/CA2984405C/fr active Active
- 2016-04-28 PL PL16722319T patent/PL3288551T3/pl unknown
- 2016-04-28 EP EP16722319.7A patent/EP3288551B1/fr active Active
- 2016-04-28 KR KR1020177034255A patent/KR102575312B1/ko active IP Right Grant
- 2016-04-28 WO PCT/FR2016/051001 patent/WO2016174360A1/fr active Application Filing
- 2016-04-28 BR BR112017023264-2A patent/BR112017023264A2/pt not_active Application Discontinuation
- 2016-04-28 JP JP2017556593A patent/JP6660401B2/ja active Active
- 2016-04-28 ES ES16722319T patent/ES2752061T3/es active Active
- 2016-04-28 CN CN201680037407.9A patent/CN107708685B/zh active Active
- 2016-04-28 AU AU2016256637A patent/AU2016256637A1/en not_active Abandoned
- 2016-04-28 RU RU2017141462A patent/RU2715889C2/ru active
-
2017
- 2017-10-26 IL IL255276A patent/IL255276A0/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018518460A5 (ja) | ||
JP2016535777A5 (ja) | ||
JP2015516496A5 (ja) | ||
RU2672575C2 (ru) | Лечение рака головного мозга | |
HRP20161718T1 (hr) | Pripravak bixa orellana za liječenje makularne degeneracije | |
CO6311066A2 (es) | Composiciones de alta densidad que contienen posaconazol y formulaciones que comprenden las mismas | |
JP2015025011A5 (ja) | ||
MD3548091T2 (ro) | Prepararea complexelor solide de ciclodextrină pentru livrarea ingredientelor farmaceutice active oftalmice | |
JP2008540528A5 (ja) | ||
JP5897592B2 (ja) | 葉酸−ラミプリルの組合せ:細胞保護性、神経保護性、および網膜保護性の眼科用組成物 | |
RU2017141462A (ru) | Композиция, содержащая норбиксин, для защиты клеток пигментного эпителия сетчатки | |
HRP20190561T1 (hr) | Postupci liječenja bolesti oka povezanih s upalom i vaskularnom proliferacijom | |
JP2018529666A5 (ja) | ||
JP2015500822A5 (ja) | ||
WO2019195761A3 (en) | Pharmacological agents for treating ocular diseases | |
HRP20210418T1 (hr) | Liječenje s syd985 pacijenata s rakom koji ne reagira na t-dm1 | |
JP2019530706A5 (ja) | ||
EP2827909A2 (en) | Fertility enhancing agent | |
Xin et al. | Ophthalmic drops with nanoparticles derived from a natural product for treating age-related macular degeneration | |
JP2019513812A5 (ja) | ||
JP2019532026A5 (ja) | ||
RU2015145134A (ru) | Местное лечение воспалительных офтальмологических заболеваний | |
RU2020119228A (ru) | Соединения, композиции и способы лечения нарушений со стороны органа зрения и заболеваний кожи | |
RU2019134423A (ru) | Наноструктурированные композиции для доставки силибинина и других активных ингредиентов для лечения глазных заболеваний | |
WO2006117666A3 (en) | Dosage forms, pharmaceutical compositions and methods for sub-tenon delivery |